Cargando…
Neoadjuvant Therapy in Patients with Pancreatic Cancer: A Disappointing Therapeutic Approach?
Pancreatic cancer is a devastating disease. It is the fourth leading cause of cancer-related death in Germany. The incidence in 2003/2004 was 16 cases per 100.000 inhabitants. Of all carcinomas, pancreatic cancer has the highest mortality rate, with one- and five-year survival rates of 25% and less...
Autores principales: | Zimmermann, Carolin, Folprecht, Gunnar, Zips, Daniel, Pilarsky, Christian, Saeger, Hans Detlev, Grutzmann, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757418/ https://www.ncbi.nlm.nih.gov/pubmed/24212810 http://dx.doi.org/10.3390/cancers3022286 |
Ejemplares similares
-
The Role of Apoptosis in the Pathology of Pancreatic Cancer
por: Samm, Nicole, et al.
Publicado: (2010) -
Simultaneous gene silencing of Bcl-2, XIAP and Survivin re-sensitizes pancreatic cancer cells towards apoptosis
por: Rückert, Felix, et al.
Publicado: (2010) -
Evaluation of survival in patients after pancreatic head resection for ductal adenocarcinoma
por: Distler, Marius, et al.
Publicado: (2013) -
Evaluation of response using FDG-PET/CT and diffusion weighted MRI after radiochemotherapy of pancreatic cancer: a non-randomized, monocentric phase II clinical trial—PaCa-DD-041 (Eudra-CT 2009-011968-11)
por: Zimmermann, Carolin, et al.
Publicado: (2020) -
Chronic pancreatitis of the pancreatic remnant is an independent risk factor for pancreatic fistula after distal pancreatectomy
por: Distler, Marius, et al.
Publicado: (2014)